Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Titan Pharma (TTNP)

Titan Pharma (TTNP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,284
  • Shares Outstanding, K 12,039
  • Annual Sales, $ 1,530 K
  • Annual Income, $ -8,780 K
  • 60-Month Beta 0.43
  • Price/Sales 4.20
  • Price/Cash Flow N/A
  • Price/Book 0.81
Trade TTNP with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.43
  • Most Recent Earnings -0.19 on 11/15/21
  • Next Earnings Date 08/15/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 397.15% ( -124.86%)
  • Historical Volatility 173.26%
  • IV Percentile 84%
  • IV Rank 40.41%
  • IV High 926.58% on 03/23/22
  • IV Low 38.09% on 02/16/22
  • Put/Call Vol Ratio 0.11
  • Today's Volume 140
  • Volume Avg (30-Day) 21
  • Put/Call OI Ratio 0.03
  • Today's Open Interest 504
  • Open Int (30-Day) 435

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -2.40
  • Growth Rate Est. (year over year) +41,725.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3990 +125.56%
on 06/07/22
1.0800 -16.67%
on 07/06/22
+0.4869 (+117.86%)
since 06/06/22
3-Month
0.3496 +157.44%
on 05/19/22
1.0800 -16.67%
on 07/06/22
+0.0049 (+0.55%)
since 04/06/22
52-Week
0.3496 +157.44%
on 05/19/22
2.4881 -63.83%
on 07/12/21
-1.5400 (-63.11%)
since 07/06/21

Most Recent Stories

More News
Titan Pharmaceuticals Announces FDA Clearance of IND Application for Nalmefene Implant

/PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that the U.S. Food and Drug Administration ("FDA") has...

TTNP : 0.9000 (+48.76%)
Activist Investing Discloses 9.9% Ownership Interest in Titan Pharmaceuticals, Inc.

NEW YORK, June 10, 2022 (GLOBE NEWSWIRE) -- David E. Lazar, Chief Executive Officer of Activist Investing LLC (together with its affiliates, “Activist...

TTNP : 0.9000 (+48.76%)
Activist Investing Announces 5.6% Ownership Interest in Titan Pharmaceuticals, Inc.

NEW YORK, April 25, 2022 (GLOBE NEWSWIRE) -- Activist Investing LLC (together with its affiliates, “Activist Investing” or “we”), today filed a Schedule...

TTNP : 0.9000 (+48.76%)
Titan Pharmaceuticals: Q3 Earnings Snapshot

SAN FRANCISCO (AP) _ Titan Pharmaceuticals Inc. (TTNP) on Monday reported a loss of $1.9 million in its third quarter.

TTNP : 0.9000 (+48.76%)
Titan Pharmaceuticals Receives Funding to Develop Combination HIV Therapeutic and Contraceptive Implant for Women in Developing Countries

/PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that it has received funding from the Bill & Melinda...

TTNP : 0.9000 (+48.76%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Titan Pharmaceuticals, Inc. is a biopharmaceutical company developingproprietary therapeutics for the treatment of central nervous system disorders, cancer, and other serious and life threatening diseases. In the central nervous system arena, the company is developing iloperidone, which is clinical...

See More

Key Turning Points

3rd Resistance Point 1.6173
2nd Resistance Point 1.3487
1st Resistance Point 1.1243
Last Price 0.9000
1st Support Level 0.6313
2nd Support Level 0.3627
3rd Support Level 0.1383

See More

52-Week High 2.4881
Fibonacci 61.8% 1.6712
Fibonacci 50% 1.4189
Fibonacci 38.2% 1.1665
Last Price 0.9000
52-Week Low 0.3496

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar